Arvinas Inc (ARVN) — Quality & forensics
As of 2026-10-19 — refreshed nightly. Closelooknet readings from an investment research diary, not ratings or advice.
The Closelooknet module scores
- Valuation 29
- Quality 27
- Growth 72
- Balance sheet 44
- Cash quality 35
- Capital allocation 75
- Momentum 12
Scores are computed nightly across the coverage universe and read relative to it — the methodology lives in the company-scoring explainer.
Financial forensics — the academic screens
Sits in the distress zone (below 1.81). The Z-Score estimates financial-distress risk from five balance-sheet and earnings ratios.
Nine binary fundamental-strength checks across profitability, leverage and operating efficiency.
Screens reported earnings for statistical manipulation patterns — above the −1.78 threshold the literature flags for earnings-manipulation risk. A screen, not an accusation.
Continue: the ARVN chart & overview
FAQ · from the current data · as of 2026-10-19
Quick answers
What is Arvinas Inc's Closelooknet quality reading?
The composite reads 43/100 across 7 modules, as of 2026-10-19: valuation 29, quality 27, growth 72, balance sheet 44, cash quality 35, capital allocation 75, momentum 12. Closelooknet scores are research diary readings, not ratings or investment advice.
What is Arvinas Inc's Altman Z-Score?
-1.42, which sits in the distress zone (below 1.81) as of 2026-10-19. The Altman Z-Score estimates financial distress risk from five balance-sheet and earnings ratios.
What is Arvinas Inc's Piotroski F-Score?
4 of 9, as of 2026-10-19. The F-Score counts nine binary fundamental-strength signals across profitability, leverage and operating efficiency.
What does Arvinas Inc's Beneish M-Score indicate?
-1.61 — above the −1.78 threshold the literature flags for earnings-manipulation risk, as of 2026-10-19. The M-Score screens reported earnings for statistical manipulation patterns; it is a screen, not an accusation.
Related in the Closelooknet universe
then Biotechnology, then Healthcare. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- HALO Halozyme Therapeutics Incindustry
- BION.SW BB Biotech AGindustry
- ONC BeiGene, Ltd.industry
- RIGL Rigel Pharmaceuticals Incindustry
- REGN Regeneronindustry
- UCB.BR UCB SAindustry
- BANB.SW BANB.SWindustry
- APGE APGE.USindustry
- ASND ASND.USindustry
- AGN.AX AGN.AXindustry
- BBIO BBIO.USindustry
- ARGX.BR ARGX.BRindustry
- ARGX ARGX.USindustry
- ABVX.PA ABVX.PAindustry
- AXSM AXSM.USindustry
- ARWR ARWR.USindustry
- CGEM CGEM.USindustry
- ALMS ALMS.USindustry
- DXCM Dexcomsector
- MEDP Medpace Holdings Incsector